Hippocratic AI, a pioneering startup dedicated to developing AI solutions that manage non-diagnostic patient-facing tasks, has successfully secured an impressive $141 million in Series B funding. This investment, which brings the company’s valuation to $1.64 billion, was led by Kleiner Perkins, as the company announced on Thursday. This round of funding follows the $53 million raised nine months ago from General Catalyst and Andreessen Horowitz, alongside a $17 million investment from Nvidia five months prior. Notably, the startup is still in its infancy, having been established less than two years ago.
While many healthcare-generative AI companies concentrate on alleviating administrative tasks, Hippocratic AI is tackling the pressing issue of healthcare professional shortages. The company is developing AI agents capable of performing straightforward tasks, including:
- Pre-operating procedures
- Remote patient monitoring
- Appointment preparation
In 2024, Hippocratic AI has also successfully signed contracts with 23 health systems and insurers. The new funding will be utilised to broaden the product’s reach into additional markets as well as expand internationally.
